Abstract
Tobacco use is a major preventable cause of premature death and disease worldwide. In this article I briefly review the extent of the problem highlighting current policies that are effective in its control. I provide information on prevalence of tobacco use and tobacco smoke exposure (TSE) among children and adolescents worldwide along with mortality data and economic data. I summarize the public policies that have been shown to be effective in reducing tobacco initiation and TSE in children using as a framework the MPOWER recommendations from the World Health Organization (WHO). I review each one of these policies – monitoring, smoke-free environments, treatment of tobacco dependence, health warnings on packages, bans on advertising, promotion and sponsorship, and tobacco taxation- and explain how they can prevent smoking among children and adolescents and their exposure to tobacco smoke. Finally, I discuss the role of the pediatrician in understanding these policies and help in their implementation.
Keywords: Adolescents, children, cigarettes, pediatricians, public policies, smoking prevention, tobacco
Current Pediatric Reviews
Title: Policies to Prevent Tobacco Use and Exposure in Children, a Global Perspective
Volume: 7 Issue: 2
Author(s): Paola Morello
Affiliation:
Keywords: Adolescents, children, cigarettes, pediatricians, public policies, smoking prevention, tobacco
Abstract: Tobacco use is a major preventable cause of premature death and disease worldwide. In this article I briefly review the extent of the problem highlighting current policies that are effective in its control. I provide information on prevalence of tobacco use and tobacco smoke exposure (TSE) among children and adolescents worldwide along with mortality data and economic data. I summarize the public policies that have been shown to be effective in reducing tobacco initiation and TSE in children using as a framework the MPOWER recommendations from the World Health Organization (WHO). I review each one of these policies – monitoring, smoke-free environments, treatment of tobacco dependence, health warnings on packages, bans on advertising, promotion and sponsorship, and tobacco taxation- and explain how they can prevent smoking among children and adolescents and their exposure to tobacco smoke. Finally, I discuss the role of the pediatrician in understanding these policies and help in their implementation.
Export Options
About this article
Cite this article as:
Morello Paola, Policies to Prevent Tobacco Use and Exposure in Children, a Global Perspective, Current Pediatric Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/157339611795735639
DOI https://dx.doi.org/10.2174/157339611795735639 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Three Dimensional Echocardiography: Recent Trends in Segmen tation Methods
Current Medical Imaging On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design Peironimev-Plus® in the Treatment of Chronic Inflammation of Tunica Albuginea (Peyronie’s Disease). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Clinical Applications of Cardiac Multi-Slice Computed Tomography
Current Medical Imaging Endothelial Function: A Surrogate Endpoint in Cardiovascular Studies?
Current Pharmaceutical Design The Comparison of Rat and Human Intestinal and Hepatic Glucuronidation of Enterolactone Derived from Flaxseed Lignans
The Natural Products Journal Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK)
Current Pharmaceutical Design Mild Cognitive Impairment: At the Crossroad of Neurodegeneration and Vascular Dysfunction
Current Alzheimer Research Age-related Changes in Pharmacodynamics: Focus on Drugs Acting on Central Nervous and Cardiovascular Systems
Current Drug Metabolism C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?
Current Pharmaceutical Design Flavonoids and Linderone from Lindera oxyphylla and their Bioactivities
Combinatorial Chemistry & High Throughput Screening Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target
Current Drug Targets Open Access High Throughput Drug Discovery in the Public Domain: A Mount Everest in the Making
Current Pharmaceutical Biotechnology Dimensional Assessment of Hypochondriacal Fears and Beliefs
Current Psychiatry Reviews Role of the Autonomic Nervous System in the Endothelial Dysfunction of the Metabolic Syndrome
Current Hypertension Reviews Estimation of Familial Combined Hyperlipoproteinemia Prevalence in a Large Rural Population: The Brisighella Heart Study
Vascular Disease Prevention (Discontinued) Prevention of Renal Complications Induced by Non- Steroidal Anti-Inflammatory Drugs
Current Medicinal Chemistry Evaluation and Comparative Correlation of Abdominal Fat Related Parameters in Obese and Non-obese Groups Using Computed Tomography
Current Medical Imaging